http://learnpsychiatry.org/w/index.php?title=Validity&feed=atom&action=history
Validity - Revision history
2024-03-28T16:48:56Z
Revision history for this page on the wiki
MediaWiki 1.25.2
http://learnpsychiatry.org/w/index.php?title=Validity&diff=4692&oldid=prev
Eugene Grudnikoff MD: /* Reliabilifty */
2016-01-23T23:02:21Z
<p><span dir="auto"><span class="autocomment">Reliabilifty</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr style='vertical-align: top;'>
<td colspan='2' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black; text-align: center;">Revision as of 23:02, 23 January 2016</td>
</tr><tr><td colspan="2" class="diff-lineno" id="L12" >Line 12:</td>
<td colspan="2" class="diff-lineno">Line 12:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>A kappa of 1.0 means 100% match in the diagnosis between clinicians. For example, diagnosis of skin and soft-tissue infections has kappa values between 0.39 and 0.43, and assessment of hand films for osteoarthrosis yields a  κ=0.54.</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>A kappa of 1.0 means 100% match in the diagnosis between clinicians. For example, diagnosis of skin and soft-tissue infections has kappa values between 0.39 and 0.43, and assessment of hand films for osteoarthrosis yields a  κ=0.54.</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability, utility, (and, where possible, convergent validity) of the proposed criteria. To accomplish this patients were evaluated by '''two''' clinicians form various mental health disciplines. This approach permitted the estimate of test-retest reliability. The trials involved evaluating over <del class="diffchange diffchange-inline">4</del>,<del class="diffchange diffchange-inline">000 </del>patients at 11 field trial sites (2) The goal was to establish intraclass kappa between 0.4 and 0.6;  κ>0.2 were considered acceptable.</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>The <ins class="diffchange diffchange-inline">[[DSM-5|</ins>DSM-5 field trials<ins class="diffchange diffchange-inline">]] </ins>were designed to evaluate the reliability, utility, (and, where possible, convergent validity) of the proposed criteria. To accomplish this patients were evaluated by '''two''' clinicians form various mental health disciplines. This approach permitted the estimate of test-retest reliability. The trials involved evaluating over <ins class="diffchange diffchange-inline">2</ins>,<ins class="diffchange diffchange-inline">200 </ins>patients at 11 field trial sites (2) The goal was to establish intraclass kappa between 0.4 and 0.6;  κ>0.2 were considered acceptable.</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===Validity===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===Validity===</div></td></tr>
<!-- diff cache key lea1028204024821-mw_:diff:version:1.11a:oldid:4678:newid:4692 -->
</table>
Eugene Grudnikoff MD
http://learnpsychiatry.org/w/index.php?title=Validity&diff=4678&oldid=prev
Eugene Grudnikoff MD: /* References */
2016-01-23T22:32:54Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr style='vertical-align: top;'>
<td colspan='2' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black; text-align: center;">Revision as of 22:32, 23 January 2016</td>
</tr><tr><td colspan="2" class="diff-lineno" id="L24" >Line 24:</td>
<td colspan="2" class="diff-lineno">Line 24:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==References==</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==References==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>1. Kraemer HC Moving Toward DSM-5: The field Trials. Am J Psychiatry 167:10, October 2010</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>1. Kraemer HC Moving Toward DSM-5: The field Trials. Am J Psychiatry 167:10, October 2010</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>2. Clarke, DE et.al. DSM-5 Field Trials in the US and Canada, Part I: Study Design, Sampling Strategy, Implementation and Analytic Approaches. Am J Psychiatry 170:1 (2013)</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>2. Clarke, DE et.al. DSM-5 Field Trials in the US and Canada, Part I: Study Design, Sampling Strategy, Implementation and Analytic Approaches. Am J Psychiatry 170:1 (2013)</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<!-- diff cache key lea1028204024821-mw_:diff:version:1.11a:oldid:4675:newid:4678 -->
</table>
Eugene Grudnikoff MD
http://learnpsychiatry.org/w/index.php?title=Validity&diff=4675&oldid=prev
Eugene Grudnikoff MD: /* References */
2016-01-23T22:07:57Z
<p><span dir="auto"><span class="autocomment">References</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr style='vertical-align: top;'>
<td colspan='2' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black; text-align: center;">Revision as of 22:07, 23 January 2016</td>
</tr><tr><td colspan="2" class="diff-lineno" id="L23" >Line 23:</td>
<td colspan="2" class="diff-lineno">Line 23:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==References==</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==References==</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>1. Clarke, DE et.al. DSM-5 Field Trials in the US and Canada, Part I: Study Design, Sampling Strategy, Implementation and Analytic Approaches. Am J Psychiatry 170:1 (2013)</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>1<ins class="diffchange diffchange-inline">. Kraemer HC Moving Toward DSM-5: The field Trials. Am J Psychiatry 167:10, October 2010</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">2</ins>. Clarke, DE et.al. DSM-5 Field Trials in the US and Canada, Part I: Study Design, Sampling Strategy, Implementation and Analytic Approaches. Am J Psychiatry 170:1 (2013)</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==Further Reading==</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==Further Reading==</div></td></tr>
<!-- diff cache key lea1028204024821-mw_:diff:version:1.11a:oldid:4674:newid:4675 -->
</table>
Eugene Grudnikoff MD
http://learnpsychiatry.org/w/index.php?title=Validity&diff=4674&oldid=prev
Eugene Grudnikoff MD: /* Reliabilifty */
2016-01-23T22:06:21Z
<p><span dir="auto"><span class="autocomment">Reliabilifty</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr style='vertical-align: top;'>
<td colspan='2' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black; text-align: center;">Revision as of 22:06, 23 January 2016</td>
</tr><tr><td colspan="2" class="diff-lineno" id="L12" >Line 12:</td>
<td colspan="2" class="diff-lineno">Line 12:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>A kappa of 1.0 means 100% match in the diagnosis between clinicians. For example, diagnosis of skin and soft-tissue infections has kappa values between 0.39 and 0.43, and assessment of hand films for osteoarthrosis yields a  κ=0.54.</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>A kappa of 1.0 means 100% match in the diagnosis between clinicians. For example, diagnosis of skin and soft-tissue infections has kappa values between 0.39 and 0.43, and assessment of hand films for osteoarthrosis yields a  κ=0.54.</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability, utility, (and, where possible, convergent validity) of the proposed criteria. To accomplish this patients were evaluated by '''two''' clinicians form various mental health disciplines. This approach permitted the estimate of test-retest reliability. The trials involved evaluating over 4,000 patients at 11 field trial sites (<del class="diffchange diffchange-inline">1</del>) The goal was to establish <del class="diffchange diffchange-inline">intercalls </del>kappa between 0.4 and 0.6<del class="diffchange diffchange-inline">, and </del> κ>0.2 <del class="diffchange diffchange-inline">are </del>considered acceptable.</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability, utility, (and, where possible, convergent validity) of the proposed criteria. To accomplish this patients were evaluated by '''two''' clinicians form various mental health disciplines. This approach permitted the estimate of test-retest reliability. The trials involved evaluating over 4,000 patients at 11 field trial sites (<ins class="diffchange diffchange-inline">2</ins>) The goal was to establish <ins class="diffchange diffchange-inline">intraclass </ins>kappa between 0.4 and 0.6<ins class="diffchange diffchange-inline">; </ins> κ>0.2 <ins class="diffchange diffchange-inline">were </ins>considered acceptable.</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===Validity===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===Validity===</div></td></tr>
<!-- diff cache key lea1028204024821-mw_:diff:version:1.11a:oldid:4673:newid:4674 -->
</table>
Eugene Grudnikoff MD
http://learnpsychiatry.org/w/index.php?title=Validity&diff=4673&oldid=prev
Eugene Grudnikoff MD at 22:04, 23 January 2016
2016-01-23T22:04:39Z
<p></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr style='vertical-align: top;'>
<td colspan='2' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black; text-align: center;">Revision as of 22:04, 23 January 2016</td>
</tr><tr><td colspan="2" class="diff-lineno" id="L12" >Line 12:</td>
<td colspan="2" class="diff-lineno">Line 12:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>A kappa of 1.0 means 100% match in the diagnosis between clinicians. For example, diagnosis of skin and soft-tissue infections has kappa values between 0.39 and 0.43, and assessment of hand films for osteoarthrosis yields a  κ=0.54.</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>A kappa of 1.0 means 100% match in the diagnosis between clinicians. For example, diagnosis of skin and soft-tissue infections has kappa values between 0.39 and 0.43, and assessment of hand films for osteoarthrosis yields a  κ=0.54.</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability, utility, (and, where possible, convergent validity) of the proposed criteria. To accomplish this patients were evaluated by '''two''' clinicians form various mental health disciplines. This approach permitted the estimate of test-retest reliability. The trials involved evaluating over 4,000 patients at 11 field trial sites (1) The goal was to establish intercalls kappa between 0.4 and 0.6.</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability, utility, (and, where possible, convergent validity) of the proposed criteria. To accomplish this patients were evaluated by '''two''' clinicians form various mental health disciplines. This approach permitted the estimate of test-retest reliability. The trials involved evaluating over 4,000 patients at 11 field trial sites (1) The goal was to establish intercalls kappa between 0.4 and 0.6<ins class="diffchange diffchange-inline">, and  κ>0.2 are considered acceptable</ins>.</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===Validity===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===Validity===</div></td></tr>
<!-- diff cache key lea1028204024821-mw_:diff:version:1.11a:oldid:4672:newid:4673 -->
</table>
Eugene Grudnikoff MD
http://learnpsychiatry.org/w/index.php?title=Validity&diff=4672&oldid=prev
Eugene Grudnikoff MD: /* Reliabilifty */
2016-01-23T22:03:26Z
<p><span dir="auto"><span class="autocomment">Reliabilifty</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr style='vertical-align: top;'>
<td colspan='2' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black; text-align: center;">Revision as of 22:03, 23 January 2016</td>
</tr><tr><td colspan="2" class="diff-lineno" id="L10" >Line 10:</td>
<td colspan="2" class="diff-lineno">Line 10:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>The measure of reliability for a diagnosis is kalle '''intraclass kappa coefficient''', a measure of how well a first diagnosis (Patient A, Clinician A) predicts a second independent one (Patient A, Clinician B).  '''Cohen’s kappa''' is a measure of validity. [http://www.dsm5.org/Research/Documents/Kraemer%20et%20al_FT%20Commentary_AJP%20Oct%202010.pdf]</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>The measure of reliability for a diagnosis is kalle '''intraclass kappa coefficient''', a measure of how well a first diagnosis (Patient A, Clinician A) predicts a second independent one (Patient A, Clinician B).  '''Cohen’s kappa''' is a measure of validity. [http://www.dsm5.org/Research/Documents/Kraemer%20et%20al_FT%20Commentary_AJP%20Oct%202010.pdf]</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability, utility, (and, where possible, convergent validity) of the proposed criteria. To accomplish this patients were evaluated by '''two''' clinicians form various mental health disciplines. This approach permitted the estimate of test-retest reliability. The trials involved evaluating over 4,000 patients at 11 field trial sites (1)</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">A kappa of 1.0 means 100% match in the diagnosis between clinicians. For example, diagnosis of skin and soft-tissue infections has kappa values between 0.39 and 0.43, and assessment of hand films for osteoarthrosis yields a  κ=0.54.</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability, utility, (and, where possible, convergent validity) of the proposed criteria. To accomplish this patients were evaluated by '''two''' clinicians form various mental health disciplines. This approach permitted the estimate of test-retest reliability. The trials involved evaluating over 4,000 patients at 11 field trial sites (1) <ins class="diffchange diffchange-inline">The goal was to establish intercalls kappa between 0.4 and 0.6.</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===Validity===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===Validity===</div></td></tr>
<!-- diff cache key lea1028204024821-mw_:diff:version:1.11a:oldid:4671:newid:4672 -->
</table>
Eugene Grudnikoff MD
http://learnpsychiatry.org/w/index.php?title=Validity&diff=4671&oldid=prev
Eugene Grudnikoff MD at 21:58, 23 January 2016
2016-01-23T21:58:54Z
<p></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr style='vertical-align: top;'>
<td colspan='2' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black; text-align: center;">Revision as of 21:58, 23 January 2016</td>
</tr><tr><td colspan="2" class="diff-lineno" id="L9" >Line 9:</td>
<td colspan="2" class="diff-lineno">Line 9:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>The measure of reliability for a diagnosis is kalle '''intraclass kappa coefficient''', a measure of how well a first diagnosis (Patient A, Clinician A) predicts a second independent one (Patient A, Clinician B).  '''Cohen’s kappa''' is a measure of validity. [http://www.dsm5.org/Research/Documents/Kraemer%20et%20al_FT%20Commentary_AJP%20Oct%202010.pdf]</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>The measure of reliability for a diagnosis is kalle '''intraclass kappa coefficient''', a measure of how well a first diagnosis (Patient A, Clinician A) predicts a second independent one (Patient A, Clinician B).  '''Cohen’s kappa''' is a measure of validity. [http://www.dsm5.org/Research/Documents/Kraemer%20et%20al_FT%20Commentary_AJP%20Oct%202010.pdf]</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability, utility, (and, where possible, convergent validity) of the proposed criteria. To accomplish this patients were evaluated by '''two''' clinicians form various mental health disciplines. This approach permitted the estimate of test-retest reliability. The trials involved evaluating over 4,000 patients at 11 field trial sites (1)</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability, utility, (and, where possible, convergent validity) of the proposed criteria. To accomplish this patients were evaluated by '''two''' clinicians form various mental health disciplines. This approach permitted the estimate of test-retest reliability. The trials involved evaluating over 4,000 patients at 11 field trial sites (1)</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<!-- diff cache key lea1028204024821-mw_:diff:version:1.11a:oldid:4670:newid:4671 -->
</table>
Eugene Grudnikoff MD
http://learnpsychiatry.org/w/index.php?title=Validity&diff=4670&oldid=prev
Eugene Grudnikoff MD at 21:58, 23 January 2016
2016-01-23T21:58:34Z
<p></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr style='vertical-align: top;'>
<td colspan='2' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black; text-align: center;">Revision as of 21:58, 23 January 2016</td>
</tr><tr><td colspan="2" class="diff-lineno" id="L8" >Line 8:</td>
<td colspan="2" class="diff-lineno">Line 8:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''Test-retest reliability''' is most inclusive measure of reliability where the same patient is observed separately by two or more raters within a close interval. It captures the variability created by patient's inconsistent report ('''internal consistency reliability''') as well as the rater variability.</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''Test-retest reliability''' is most inclusive measure of reliability where the same patient is observed separately by two or more raters within a close interval. It captures the variability created by patient's inconsistent report ('''internal consistency reliability''') as well as the rater variability.</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability (and, where possible, validity) of the proposed criteria. To accomplish this patients were evaluated by two clinicians form various mental health disciplines. This involved evaluating over 4,000 patients at 11 field trial sites (1)</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">The measure of reliability for a diagnosis is kalle '''intraclass kappa coefficient''', a measure of how well a first diagnosis (Patient A, Clinician A) predicts a second independent one (Patient A, Clinician B).  '''Cohen’s kappa''' is a measure of validity. [http://www.dsm5.org/Research/Documents/Kraemer%20et%20al_FT%20Commentary_AJP%20Oct%202010.pdf]</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>The DSM-5 field trials were designed to evaluate the reliability<ins class="diffchange diffchange-inline">, utility, </ins>(and, where possible, <ins class="diffchange diffchange-inline">convergent </ins>validity) of the proposed criteria. To accomplish this patients were evaluated by <ins class="diffchange diffchange-inline">'''</ins>two<ins class="diffchange diffchange-inline">''' </ins>clinicians form various mental health disciplines. This <ins class="diffchange diffchange-inline">approach permitted the estimate of test-retest reliability. The trials </ins>involved evaluating over 4,000 patients at 11 field trial sites (1)</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===Validity===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===Validity===</div></td></tr>
<!-- diff cache key lea1028204024821-mw_:diff:version:1.11a:oldid:4669:newid:4670 -->
</table>
Eugene Grudnikoff MD
http://learnpsychiatry.org/w/index.php?title=Validity&diff=4669&oldid=prev
Eugene Grudnikoff MD: /* Reliabilifty */
2016-01-23T21:44:17Z
<p><span dir="auto"><span class="autocomment">Reliabilifty</span></span></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr style='vertical-align: top;'>
<td colspan='2' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black; text-align: center;">Revision as of 21:44, 23 January 2016</td>
</tr><tr><td colspan="2" class="diff-lineno" id="L8" >Line 8:</td>
<td colspan="2" class="diff-lineno">Line 8:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''Test-retest reliability''' is most inclusive measure of reliability where the same patient is observed separately by two or more raters within a close interval. It captures the variability created by patient's inconsistent report ('''internal consistency reliability''') as well as the rater variability.</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''Test-retest reliability''' is most inclusive measure of reliability where the same patient is observed separately by two or more raters within a close interval. It captures the variability created by patient's inconsistent report ('''internal consistency reliability''') as well as the rater variability.</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">Measures of reliability include inter</del>-<del class="diffchange diffchange-inline">rater </del>reliability, <del class="diffchange diffchange-inline">test-retest reliability</del>, <del class="diffchange diffchange-inline">and internal consistency reliability</del>.</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">The DSM</ins>-<ins class="diffchange diffchange-inline">5 field trials were designed to evaluate the </ins>reliability <ins class="diffchange diffchange-inline">(and</ins>, <ins class="diffchange diffchange-inline">where possible</ins>, <ins class="diffchange diffchange-inline">validity) of the proposed criteria</ins>. <ins class="diffchange diffchange-inline">To accomplish this patients were evaluated by two clinicians form various mental health disciplines. This involved evaluating over 4,000 patients at 11 field trial sites (1)</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">===Validity===</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>In psychiatry there is a particular issue with assessing the validity of the diagnostic categories themselves. In this context:</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>In psychiatry there is a particular issue with assessing the validity of the diagnostic categories themselves. In this context:</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>* '''Construct validity''' includes (at least) content, discriminant, and convergent validity. It answers the question: Are we measuring what we want to measure?</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>* '''Construct validity''' includes (at least) content, discriminant, and convergent validity. It answers the question: Are we measuring what we want to measure?</div></td></tr>
<tr><td colspan="2" class="diff-lineno" id="L17" >Line 17:</td>
<td colspan="2" class="diff-lineno">Line 18:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>* predictive validity refers mainly to diagnostic stability over time</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>* predictive validity refers mainly to diagnostic stability over time</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">==References==</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">1. Clarke, DE et.al. DSM-5 Field Trials in the US and Canada, Part I: Study Design, Sampling Strategy, Implementation and Analytic Approaches. Am J Psychiatry 170:1 (2013)</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==Further Reading==</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==Further Reading==</div></td></tr>
<!-- diff cache key lea1028204024821-mw_:diff:version:1.11a:oldid:4668:newid:4669 -->
</table>
Eugene Grudnikoff MD
http://learnpsychiatry.org/w/index.php?title=Validity&diff=4668&oldid=prev
Eugene Grudnikoff MD at 21:35, 23 January 2016
2016-01-23T21:35:41Z
<p></p>
<table class='diff diff-contentalign-left'>
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr style='vertical-align: top;'>
<td colspan='2' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black; text-align: center;">Revision as of 21:35, 23 January 2016</td>
</tr><tr><td colspan="2" class="diff-lineno" id="L1" >Line 1:</td>
<td colspan="2" class="diff-lineno">Line 1:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==Definitions==</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==Definitions==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>To be valid, the result of a test has to accurately (i.e. reliably) answer the question that the test is intended to answer.  </div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>To be valid, the result of a test has to accurately (i.e. reliably) answer the question that the test is intended to answer.  </div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> </div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">===Reliabilifty===</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>'''Reliability''' refers to consistency of a measuring instrument. Thus, reliability is necessary but not sufficient for validity.</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>'''Reliability''' refers to consistency of a measuring instrument. Thus, reliability is necessary but not sufficient for validity.</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Inverse of reliability is "random error."</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Inverse of reliability is "random error." <ins class="diffchange diffchange-inline">Reliability in any area of medicine is affected by 1) how well patients present a sign/symptom (e.g. consistent answers, quality of X-ray) and 2) how well the examiner evaluates the answer or the result.</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">*'''Intrarater reliability''' is a measure of how well the same rater be asked to “blindly” review the same patient material two or more times.</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">*'''Interrater reliability''' requires that two or more different raters review the same patient material.</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">*'''Test-retest reliability''' is most inclusive measure of reliability where the same patient is observed separately by two or more raters within a close interval. It captures the variability created by patient's inconsistent report ('''internal consistency reliability''') as well as the rater variability.</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>Measures of reliability include inter-rater reliability, test-retest reliability, and internal consistency reliability.</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>Measures of reliability include inter-rater reliability, test-retest reliability, and internal consistency reliability.</div></td></tr>
<!-- diff cache key lea1028204024821-mw_:diff:version:1.11a:oldid:4369:newid:4668 -->
</table>
Eugene Grudnikoff MD